1066

Shandong Weigao Group Medical Polymer Co Ltd

1066.HK weigaogroup.com + Research + Basket
3.35
-0.01 (-0.15%)
HKD · HK
52-week range
2.92
5.71
Trading at 15% of the 52-week range
Market Cap
15.01B
P/E Ratio
10.14
Forward P/E
9.40
Book Value
6.30
Div. Yield
4.33%
% Institutions
21.12%
% Insiders
47.72%

1 Year

-38.6%

3 Year

-44.7%

10 Year

-19.1%
Description

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company offers medical device products, including safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; pharma packaging products comprising prefilled drug delivery system, pharmaceutical packaging consumables, and automatic drug delivery systems; and orthopedic products that include spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables. It also provides interventional products, such as tumor, vascular, and nursing interventions, as well as blood management products, including whole blood collection consumables and blood transfusion equipment. In addition, the company manufactures and sells medical PVC granules, plastic packing bags, and carton boxes; manufacture and sale of medical polymer materials and products; injection puncture instruments; computer technical services; and X-ray based irradiation machines. Further, it provides finance leasing, factoring, and consulting services. The company was founded in 1988 and is based in Weihai, the People's Republic of China.

Actions

Add an action for 1066.HK, or sign in to see your action list.

Company Information

▼
Company Name
Shandong Weigao Group Medical Polymer Co Ltd
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
HK
ISIN: CNE100000171
Currency: HKD
Full Time Employees: 13,310
Phone: 86 400 646 6666
Fiscal Year End: December
IPO Date: Feb 27, 2004
Description:

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company offers medical device products, including safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; pharma packaging products comprising prefilled drug delivery system, pharmaceutical packaging consumables, and automatic drug delivery systems; and orthopedic products that include spine, joint, trauma, sports medicine, bone repair material, and spinal endoscope products, as well as orthopedic devices, PRP treatment consumables, and negative pressure drainage consumables. It also provides interventional products, such as tumor, vascular, and nursing interventions, as well as blood management products, including whole blood collection consumables and blood transfusion equipment. In addition, the company manufactures and sells medical PVC granules, plastic packing bags, and carton boxes; manufacture and sale of medical polymer materials and products; injection puncture instruments; computer technical services; and X-ray based irradiation machines. Further, it provides finance leasing, factoring, and consulting services. The company was founded in 1988 and is based in Weihai, the People's Republic of China.

Address:

1 Weigao Road, Weihai, China, 264210

People

▼

Directors & Officers

Name Title Year Born
Mr. Jing Long Executive Chairman of the Board & Compliance Officer 1975
Mr. Rinan Cong CEO & Executive Director 1981
Mr. Junqiang Lu Executive Director 1974
Mr. Daoming Wang Executive Director 1979
Mr. Xue Feng Wu Chief Financial Officer 1978
Ms. Miu Ling Wong ACIS, FCIS, FCS Company Secretary 1969

Financial Highlights

▼
Market Cap: $15.01B
EBITDA: $2.73B
P/E Ratio: $10.14
PEG Ratio: $0.69
Book Value: $6.30
Dividend/Share: $0.15
Dividend Yield: 4.33%
Earnings/Share: $0.00
Profit Margin: 10.14%
Operating Margin: 16.49%
ROA (TTM): 3.14%
ROE (TTM): 5.68%
Revenue (TTM): $13.59B
Revenue/Share (TTM): $3.00
Earnings Growth (YOY): -22.70%
Revenue Growth (YOY): 3.10%

Valuation Metrics

Enterprise Value: $9.54B
Trailing P/E: 10.14
Forward P/E: 9.40

Shares Statistics

Shares Outstanding: 4.44B
Shares Float: 2.36B
% Insiders: 47.72%
% Institutions: 21.12%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$13.39B
Cost of Goods Sold
adjust
$-7.06B
Gross Profit
subtotal
$6.33B
SG&A
adjust
$-1.38B
R&D
adjust
$-793.99M
Other Operating Expense
adjust
$-2.45B
Operating Income
subtotal
$1.70B
Other / Non-Operating Items
adjust
$-86.69M
Net Income
subtotal
$1.61B

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about 1066.HK!